embody vs Medvi vs welludr: $49, $99 or $41?
Last updated: Sep 1, 2026
Medically reviewed by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Medically reviewed on Reviewed · Written by Treatments Hub Research Team
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
Here’s the short version
welludr is the cheapest at $41/month - a rate that locks on a 12-month plan. embody's $49 is flat with zero commitment and a refund if a provider doesn't approve you. Medvi's $99 promo is the all-inclusive, high-touch option - video visits, free dietician, care coaching.
Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery
Visit embodyembody vs Medvi vs welludr: side by side
Real published prices and terms - the differences that actually decide this matchup.
| embody | Medvi | welludr | |
|---|---|---|---|
| Semaglutide | $49/mo, flat at every dose | $99/mo promo (reg. $199), all-inclusive | $41/mo (12-month plan), same price at every dose |
| Tirzepatide | $99/mo | $166/mo promo (reg. $299) | $71/mo |
| Billing & commitment | Monthly - no commitment, cancel anytime | Monthly, all-inclusive - no surprise charges; HSA/FSA approved | Monthly billing - best rate locks on a 12-month plan |
| Shipping | Free 1-2 day, tracked & insured | Free shipping | Free, every 4 weeks, discreet packaging |
| Support | Licensed doctors, medical director & nursing team | Video visits + free dietician & care coaching | Medical Weight-Care Coach on every plan |
| Guarantee / refund | Full refund if you're not approved | - | Weight-loss warranty (terms on site) |
| Standout | LegitScript-certified; 503A pharmacies | All-inclusive price; HSA/FSA approved | 1M+ patients; board-certified specialists |
Our verdict
Decide on commitment first, support second. Ready to commit to a year: welludr - the $41 lock is the best per-month rate in the market, and its weight-loss warranty backs the plan. Not ready to commit to anything: embody - $49 flat, cancel anytime, refunded if not approved. Know from experience that you quit without someone checking in: Medvi - the $30 premium over embody buys video visits, a dietician and coaching. All three prescribe the same compounded semaglutide after a licensed-provider review.
embody vs Medvi vs welludr: FAQs
Which is cheapest: embody, Medvi or welludr?
For compounded semaglutide: welludr at $41/month (the rate locks on a 12-month plan), embody at $49/month flat with no commitment, Medvi at $99/month promotional (regularly $199) all-inclusive. For tirzepatide: welludr $71, embody $99, Medvi $166 promotional (regularly $299).
Which is best if I don't want a commitment?
embody - $49/month flat, billed month to month, cancel anytime, and a full refund if a licensed provider doesn't approve you for treatment. Medvi also bills monthly with no prepaid term. welludr's best rate ($41) requires a 12-month plan.
Do any of the three offer a guarantee?
welludr backs treatment with a weight-loss warranty (terms on its site), and embody refunds you in full if you're not approved. Medvi doesn't advertise a results guarantee - its pitch is the all-inclusive support model instead.
Break it down two at a time
The head-to-head comparisons between these providers.
Medical disclaimer
This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.
Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.
Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)

